ATE476444T1 - Antigene gegen das leberstadium von plasmodium - Google Patents

Antigene gegen das leberstadium von plasmodium

Info

Publication number
ATE476444T1
ATE476444T1 AT06815681T AT06815681T ATE476444T1 AT E476444 T1 ATE476444 T1 AT E476444T1 AT 06815681 T AT06815681 T AT 06815681T AT 06815681 T AT06815681 T AT 06815681T AT E476444 T1 ATE476444 T1 AT E476444T1
Authority
AT
Austria
Prior art keywords
plasmodium
antigens against
liver stage
liver
stage
Prior art date
Application number
AT06815681T
Other languages
English (en)
Inventor
Stefan Kappe
Lawrence Bergman
Alice Tarun
Original Assignee
Seattle Biomedical Res Inst
Reed Army Inst Research
Philadelphia Health & Educatio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seattle Biomedical Res Inst, Reed Army Inst Research, Philadelphia Health & Educatio filed Critical Seattle Biomedical Res Inst
Application granted granted Critical
Publication of ATE476444T1 publication Critical patent/ATE476444T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT06815681T 2005-09-30 2006-09-29 Antigene gegen das leberstadium von plasmodium ATE476444T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72225405P 2005-09-30 2005-09-30
US74838205P 2005-12-08 2005-12-08
PCT/US2006/037851 WO2007041216A2 (en) 2005-09-30 2006-09-29 Plasmodium liver stage antigens

Publications (1)

Publication Number Publication Date
ATE476444T1 true ATE476444T1 (de) 2010-08-15

Family

ID=37592456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06815681T ATE476444T1 (de) 2005-09-30 2006-09-29 Antigene gegen das leberstadium von plasmodium

Country Status (7)

Country Link
US (2) US7722889B2 (de)
EP (2) EP1937715B1 (de)
AP (1) AP2008004448A0 (de)
AT (1) ATE476444T1 (de)
BR (1) BRPI0616602A2 (de)
DE (1) DE602006015985D1 (de)
WO (1) WO2007041216A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI477602B (zh) * 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
US9333249B2 (en) * 2006-02-09 2016-05-10 Educational Foundation Jichi Medical University Recombinant baculovirus vaccine
EP2163627A1 (de) 2008-09-12 2010-03-17 Bernhard-Nocht-Institut für Tropenmedizin Abgeschwächtes Leberstufen-Plasmodium und Impfstoff damit
US20110229514A1 (en) * 2009-03-16 2011-09-22 Denise Doolan Vaccine and immunization method using plasmodium antigen 2
CA3002946C (en) * 2009-11-05 2021-11-02 The United States Of America As Represented By The Secretary Of The Navy Plasmodium falciparum sporozoite and liver stage antigens
US20120244178A1 (en) * 2011-03-25 2012-09-27 Denise Doolan Plasmodium falciparum antigens
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
EP2916862B1 (de) 2012-11-12 2020-01-08 GenVec, Inc. Malariaantigene und verfahren zur verwendung
WO2014084333A1 (ja) * 2012-11-30 2014-06-05 国立大学法人三重大学 マラリア原虫肝臓ステージの感染に関わる原虫蛋白質
EP2923709A1 (de) * 2014-03-28 2015-09-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Mehrstufiger Mehrkomponenten-Malariaimpfstoff
EP2992895A1 (de) 2014-09-08 2016-03-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Mehrstufiger Dreikomponenten-Malariaimpfstoff
EP3081575A1 (de) 2015-04-12 2016-10-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anti-plasmodium-parasiten-antikörper
DE102015210919A1 (de) 2015-06-15 2016-12-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. MEMS-Wandler zum Interagieren mit einem Volumenstrom eines Fluids und Verfahren zum Herstellen desselben
WO2018085444A1 (en) 2016-11-01 2018-05-11 Washington University COMPOSITIONS COMPRISING CelTOS IMMUNOGENS AND ANTIBODIES AND METHOD OF USE THEREOF
US12544441B2 (en) 2016-11-01 2026-02-10 Washington University Compositions comprising CelTOS immunogens and antibodies and method of use thereof
EP3600399A4 (de) * 2017-03-30 2021-03-24 The United States of America, as represented by the Secretary of the Navy Verfahren und zusammensetzungen zur impfung gegen malaria
SG11201909265QA (en) 2017-04-19 2019-11-28 Inst Res Biomedicine Plasmodium sporozoite npdp peptides as vaccine and target novel malaria vaccines and antibodies binding to
DE102017206766A1 (de) 2017-04-21 2018-10-25 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Mems-wandler zum interagieren mit einem volumenstrom eines fluids und verfahren zum herstellen desselben

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4372945A (en) 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
IL61904A (en) 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5288707A (en) 1990-08-13 1994-02-22 Sandoz Ltd. Borolysine peptidomimetics
GB9020438D0 (en) * 1990-09-19 1990-10-31 Imperial College Plasmodium liver stage antigens
US5552534A (en) 1991-08-22 1996-09-03 The Trustees Of The University Of Pennsylvania Non-Peptide peptidomimetics
US5550251A (en) 1991-12-12 1996-08-27 The Trustees Of The University Of Pennsylvania Alicyclic peptidomimetics
US5821231A (en) 1993-12-06 1998-10-13 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using same
IL109943A (en) 1994-06-08 2006-08-01 Develogen Israel Ltd Conformationally constrained backbone cyclized peptide analogs
US5817626A (en) 1995-03-14 1998-10-06 Praecis Pharmaceuticals Incorporated Modulators of beta-amyloid peptide aggregation
US5811515A (en) 1995-06-12 1998-09-22 California Institute Of Technology Synthesis of conformationally restricted amino acids, peptides, and peptidomimetics by catalytic ring closing metathesis
US20030133944A1 (en) 2001-04-05 2003-07-17 Smithkline Beecham Biologicals S.A. Vaccine composition against malaria
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
ATE420179T1 (de) 1999-09-01 2009-01-15 Us Gov Health & Human Serv Identifizierung des plasmodium falciparum erythrozyt membranprotein 1 (pfemp1) gebietes, das adhäsion zum chondroitin sulfat a vermittelt
US7029685B2 (en) 2001-03-26 2006-04-18 The United States Of America As Represented By The Secretary Of The Army Plasmodium falciparum AMA-1 protein and uses thereof
AU2002365202A1 (en) 2001-11-09 2003-09-02 Entremed, Inc. Synthetic genes for malarial proteins and methods of use
CA2551193C (en) 2003-12-19 2011-02-01 Seattle Biomedical Research Institute Live genetically attenuated malaria vaccine

Also Published As

Publication number Publication date
EP1937715A2 (de) 2008-07-02
US7722889B2 (en) 2010-05-25
WO2007041216A2 (en) 2007-04-12
DE602006015985D1 (de) 2010-09-16
US20100166794A1 (en) 2010-07-01
US8318183B2 (en) 2012-11-27
AP2008004448A0 (en) 2008-04-30
BRPI0616602A2 (pt) 2011-06-28
EP2264058A2 (de) 2010-12-22
EP2264058A3 (de) 2011-03-23
EP1937715B1 (de) 2010-08-04
US20090017055A1 (en) 2009-01-15
WO2007041216A3 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
ATE476444T1 (de) Antigene gegen das leberstadium von plasmodium
ATE501174T1 (de) Antikörper gegen madcam
ATE427121T1 (de) Gegen gewebefaktor gerichtete antikírper als antikoagulantien
NO20051704D0 (no) Virvler
PT1920065T (pt) Anticorpos anti-alfavbeta6 e suas utilizações
PL2281830T3 (pl) Szczepionka przeciw wirusowi ospy wietrznej i półpaśca
DE502005010604D1 (de) Strömungsarbeitsmaschine
DK1800693T3 (da) Adjuvans-terapi ved anvendelse af anti-glypican 3 antistoffer
EP1746104A4 (de) Neues lösliches cd14-antigen
AT502121A3 (de) Rastbefestigung von leuchtenbauteilen
DE602005011886D1 (de) Kochherd
EP1976987A4 (de) Neues antigen im zusammenhang mit krebs
DE502005007580D1 (de) Baugruppe
DK1815144T3 (da) Skovlhjul
DE602005022801D1 (de) Umrichter
ITPD20040270A1 (it) Struttura perfezionata di muffola
DE602005014972D1 (de) Teilchen
DE602005000799D1 (de) Flanschstruktur
DE502004001591D1 (de) Geräteblende
ATA152004A (de) Lesepult
DE502004006136D1 (de) Verrastung von Baugruppen
FI6465U1 (fi) Invertteri
FI6464U1 (fi) Invertteri
FI20045458A0 (fi) Kiuas
FI20040451L (fi) Pyörrehajottaja

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties